Friday, November 20, 2026 | 04:14 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Aurobindo Pharma Ltd Quarterly Results

Q2 FY26-27 Results Summary

Revenue

The revenue stands at ₹10,263.29 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.16 per cent from ₹9,150.35 crore. This corresponds to a year-on-year *(YoY) growth of 23.87 per cent.

Operating Profit

Operating Profit stands at ₹2,152.81 crore, reflecting a quarter-on-quarter *(QoQ) increase of 17.04 per cent from ₹1,839.34 crore. This corresponds to a year-on-year *(YoY) growth of 28.29 per cent.

PBDT

PBDT stands at ₹2,218.82 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.84 per cent from ₹2,001.91 crore. This corresponds to a year-on-year *(YoY) growth of 30.13 per cent.

Profit Before Tax

Profit Before Tax stands at ₹1,687.67 crore, reflecting a quarter-on-quarter *(QoQ) increase of 11.39 per cent from ₹1,515.09 crore. This corresponds to a year-on-year *(YoY) growth of 32.27 per cent.

Net Profit

Net Profit stands at ₹1,123.84 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.90 per cent from ₹1,032.03 crore. This represents a 32.51 per cent year-on-year *(YoY) growth for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Aurobindo Pharma Ltd Earnings

Data not available

Aurobindo Pharma Ltd Earning Charts

Revenue from Operations

in ₹ cr

EBITDA

in ₹ cr

Profit before Tax

in ₹ cr

Net Profit

in ₹ cr

Aurobindo Pharma Ltd Research Reports

ActionTarget Price (₹)BrokerDateReports
Buy 1,610JM Financial23-Mar-2026
Buy 1,430Motilal Oswal04-Dec-2025
Buy 1,460Edelweiss Securities20-Jun-2025
Buy 1,387JM Financial28-May-2025
Buy 1,370Motilal Oswal28-May-2025

Aurobindo Pharma Ltd Financial Reports

Filter By:
Loading...

Aurobindo Pharma Ltd Stock Prices Compare with Peers

Company1 Day1 Week1 month3 month6 month1 Year
Aurobindo Pharma-0.65%0.41%13.90%10.82%16.09%48.95%
Dr Reddy's Labs-0.54%0.76%12.35%18.34%5.47%11.73%
Cipla-0.07%1.50%7.70%-0.79%0.95%-6.38%
Mankind Pharma1.14%1.33%16.62%12.14%5.77%18.59%
Lupin0.55%1.90%2.71%-8.34%-12.05%-0.92%
Glenmark Pharma.1.03%0.73%20.09%14.83%10.82%43.51%
Alkem Lab0.41%0.51%4.05%-4.29%-6.06%-9.39%

Company Info

Company Information

Chairman & Independent Directo : M R Kumar

Vice Chairman & M.D. : Kambam Nityananda Reddy

E D & Wholetime Director : M Madan Mohan Reddy

Non Executive Director : P V Ramprasad Reddy

Non-Exec & Non-Independent Dir : Penaka Sarath Chandra Reddy

Independent Non Exe. Director : Girish Paman Vanvari

Independent Non Exe. Director : Santanu Mukherjee

Non-Exec & Non-Independent Dir : Satakarni Makkapati

Independent Non Exe. Director : Punita Kumar Sinha

Company Sec. & Compli. Officer : B Adi Reddy

Aurobindo Pharma Ltd News

Data Not Available